The start of the new year often brings change. Here at Life Science Leader magazine, one of our biggest changes is that I have now assumed the role of chief editor. Perhaps you are asking yourself, what happened to Dan Schell? For the past 24 issues, Dan has been doing yeoman’s work. In addition to serving as chief editor for Life Science Leader, he also worked as the editorial director for Jameson Publishing, overseeing three other monthly publications. Dan is still with us and will continue to work with Life Science Leader, though in more of a “behind-the-scenes” capacity. I look forward to working closely with him to continue making our magazine an essential business tool for life science executives.
As for me, prior to joining Life Science Leader I worked in the biopharmaceutical industry in a variety of field-based positions, including sales, training, and management. During my 17-year career, I had the opportunity to work for Mead Johnson Nutritionals, a part of Bristol-Myers Squibb, and Organon BioSciences, which was acquired by Schering-Plough and later merged with Merck. In addition to my day job, I wrote and coauthored a variety of articles in peer-reviewed academic journals and industry publications primarily focused on the biopharmaceutical industry. I also served as a speaker at a variety of international pharmaceutical and marketing conferences. I believe these experiences will help me be successful in my new role, but I also know I need your help.
This past year Life Science Leader covered a variety of topics, many of which were ideas submitted by you. Our covers featured executives from Fortune 500 companies as well as some that have yet to become household names. All shared a common thread: a willingness to share a best business practice. We intend to continue these trends in 2011.
So, if you have a story you think would benefit our readers, I want to hear about it. And remember, some articles published in the magazine have additional information available on our website (www.lifescienceleader.com). For example, we’ve added some important information to the November issue’s article on accelerated proof-of-concept programs in clinical studies. At our website, you may also find content you did not see in the magazine, such as the 2010 AAPS Annual Meeting Recap.
Email, call — or better yet — come see me at one of the many shows I plan on attending this year. Together, we can continue to make Life Science Leader a valuable business resource and unlike any other industry publication.